checkAd

     104  0 Kommentare Alkermes to Take Part in the Cantor Virtual Global Healthcare Conference

    DUBLIN, Sept. 22, 2021 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) announced today that management will participate in a fireside chat at the Cantor Virtual Global Healthcare Conference on Wednesday, Sept. 29, 2021 at 8:40 a.m. ET (1:40 p.m. BST). The presentation may be accessed under the Investors tab on www.alkermes.com and will be archived for 14 days.

    About Alkermes plc

    Alkermes plc is a fully-integrated, global biopharmaceutical company developing innovative medicines in the fields of neuroscience and oncology. The company has a portfolio of proprietary commercial products focused on addiction, schizophrenia and bipolar I disorder, and a pipeline of product candidates in development for neurodegenerative disorders and cancer. Headquartered in Dublin, Ireland, Alkermes plc has an R&D center in Waltham, Massachusetts; a research and manufacturing facility in Athlone, Ireland; and a manufacturing facility in Wilmington, Ohio. For more information, please visit Alkermes' website at www.alkermes.com. 

    Contact:
    Alex Braun
    Investor Relations
    +1 781 296 8493

     

    Alkermes plc Logo

    Logo - https://mma.prnewswire.com/media/616416/Alkermes_plc_Logo.jpg

    Lesen Sie auch




    PR Newswire (engl.)
    0 Follower
    Autor folgen
    RSS-Feed abonnieren

    Weitere Artikel des Autors


    Verfasst von PR Newswire (engl.)
    1 im Artikel enthaltener WertIm Artikel enthaltene Werte
    Alkermes to Take Part in the Cantor Virtual Global Healthcare Conference DUBLIN, Sept. 22, 2021 /PRNewswire/ - Alkermes plc (Nasdaq: ALKS) announced today that management will participate in a fireside chat at the Cantor Virtual Global Healthcare Conference on Wednesday, Sept. 29, 2021 at 8:40 a.m. ET (1:40 p.m. BST). …